Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) hit a new 52-week high on Tuesday after B. Riley raised their price target on the stock from $72.00 to $82.00. B. Riley currently has a buy rating on the stock. Axcelis Technologies traded as high as $67.33 and last traded at $67.29, with a volume of 1516 shares. The stock had previously closed at $63.45.
A number of other research firms also recently issued reports on ACLS. Needham & Company LLC increased their target price on shares of Axcelis Technologies from $50.00 to $64.00 and gave the stock a “buy” rating in a research report on Friday, November 5th. Zacks Investment Research raised shares of Axcelis Technologies from a “hold” rating to a “buy” rating and set a $68.00 target price for the company in a research report on Monday, November 8th. Finally, Stifel Nicolaus increased their price objective on shares of Axcelis Technologies from $52.00 to $67.00 and gave the company a “buy” rating in a research report on Thursday, November 4th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $61.67.
In other news, EVP Douglas A. Lawson sold 1,217 shares of the stock in a transaction that occurred on Monday, November 8th. The stock was sold at an average price of $62.41, for a total transaction of $75,952.97. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Mary G. Puma sold 1,000 shares of the firm’s stock in a transaction on Thursday, November 11th. The stock was sold at an average price of $62.06, for a total value of $62,060.00. The disclosure for this sale can be found here. Insiders sold 12,043 shares of company stock valued at $757,956 in the last ninety days. 2.11% of the stock is owned by corporate insiders.
A popular Seattle cannabis manufacturer is now partnering with other companies to produce a new line of cannabis-infused beverages. It’s perfect timing. A new report reveals cannabis beverage sales will reach $2.8 billion by 2025, expanding at an annual compounded rate of 17.8%.
Institutional investors and hedge funds have recently made changes to their positions in the stock. FMR LLC lifted its stake in Axcelis Technologies by 77.3% during the second quarter. FMR LLC now owns 642 shares of the semiconductor company’s stock worth $26,000 after purchasing an additional 280 shares during the last quarter. Newbridge Financial Services Group Inc. lifted its stake in Axcelis Technologies by 183.0% during the third quarter. Newbridge Financial Services Group Inc. now owns 750 shares of the semiconductor company’s stock worth $35,000 after purchasing an additional 485 shares during the last quarter. US Bancorp DE bought a new position in Axcelis Technologies during the second quarter worth $31,000. Advisor Group Holdings Inc. lifted its stake in Axcelis Technologies by 137.5% during the third quarter. Advisor Group Holdings Inc. now owns 1,563 shares of the semiconductor company’s stock worth $74,000 after purchasing an additional 905 shares during the last quarter. Finally, Koshinski Asset Management Inc. bought a new stake in Axcelis Technologies in the third quarter valued at $102,000. Hedge funds and other institutional investors own 86.14% of the company’s stock.
The company has a quick ratio of 2.72, a current ratio of 4.16 and a debt-to-equity ratio of 0.09. The company has a market capitalization of $2.26 billion, a P/E ratio of 27.95 and a beta of 1.49. The business has a 50 day simple moving average of $55.62 and a 200-day simple moving average of $47.10.
Axcelis Technologies (NASDAQ:ACLS) last posted its earnings results on Wednesday, November 3rd. The semiconductor company reported $0.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.11. The company had revenue of $176.69 million for the quarter, compared to analysts’ expectations of $170.20 million. Axcelis Technologies had a return on equity of 14.95% and a net margin of 13.40%. During the same period last year, the business posted $0.32 earnings per share. Equities analysts forecast that Axcelis Technologies, Inc. will post 2.67 EPS for the current fiscal year.
About Axcelis Technologies (NASDAQ:ACLS)
Axcelis Technologies, Inc engages in the manufacture of capital equipment for the semiconductor chip manufacturing industry. It ion implantation systems product line includes high current, medium current, and high energy implanters. It also offers post-sales equipment service and support, such as spare parts, equipment upgrades, used equipment, maintenance services, and customer training.
Read More: Roth IRA
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to
Before you consider Axcelis Technologies, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Axcelis Technologies wasn’t on the list.
While Axcelis Technologies currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.